Piotr Garstecki
Algemeen Directeur bij SCOPE FLUIDICS S.A.
Profiel
Piotr Garstecki is the founder of Scope Fluidics SA and Curiosity Diagnostics Sp zoo, which were founded in 2010 and 2012 respectively.
At Scope Fluidics SA, he held the title of Chairman-Management Board, and at Curiosity Diagnostics Sp zoo, he held the title of Member-Management Board.
Dr. Garstecki earned a doctorate degree from the Polish Academy of Sciences in 2002.
Actieve functies van Piotr Garstecki
Bedrijven | Functie | Begin |
---|---|---|
SCOPE FLUIDICS S.A. | Algemeen Directeur | - |
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Oprichter | 01-01-2012 |
Opleiding van Piotr Garstecki
Polish Academy of Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SCOPE FLUIDICS S.A. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Commercial Services |